Table 1 Baseline characteristics of the remimazolam-based and propofol-based total intravenous anesthesia
Characteristics | Remimazolam group (n = 28) | Propofol group (n = 29) | P-value |
|---|---|---|---|
Age, years | 45 (13.4) | 51 (12.1) | 0.090 |
Female sex | 21 (75.0) | 19 (65.5) | 0.622 |
Height, cm | 160.6 (157.2–168.4) | 158.4 (153.8–167.0) | 0.458 |
Weight, kg | 61.8 (55.2–72.2) | 57.5 (52.7–68.0) | 0.131 |
BMI, kg m−2 | 24.3 (22.8–26.0) | 22.6 (20.9–25.3) | 0.112 |
ASA physical status, I/II | 16 (57.1)/12 (42.9) | 17 (58.6)/12 (41.4) | > 0.999 |
Preoperative QoR-15 K score | 146 (140–150) | 145 (135–150) | 0.280 |
Apfel score, 0/1/2/3, n (%) | 1 (3.6)/5 (17.9)/21 (75.0)/1 (3.6) | 1 (3.4)/8 (27.6)/19 (65.5)/1 (3.4) | 0.855 |
Type of surgery | 0.358 | ||
Total thyroidectomy | 9 (32.1) | 7 (24.1) | |
Right thyroid lobectomy | 14 (50.0) | 12 (41.4) | |
Left thyroid lobectomy | 5 (17.9) | 10 (34.5) | |
Duration of surgery, min | 85 (70–98) | 85 (75–105) | 0.689 |
Intraoperative remimazolam, mg | 175 (144–208) | - | |
Intraoperative propofol, mg | - | 800 (603–942) | |
Intraoperative remifentanil, μg | 660 (536–946) | 698 (558–889) | 0.949 |